Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Industry Summary Page

Industry: pharmaceuticals
Penalty Total since 2000: $116,245,163,450
Number of Records: 1,270
Note: The totals include only those entries matched to a parent company. The industry designation is the primary one for the parent's operations overall. The totals are adjusted to account for the fact that each parent's entries may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. They are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the individual records list below.
Top 10 Current Parent CompaniesTotal Penalty $Number of Records
Johnson & Johnson$24,497,162,77088
Pfizer$10,948,368,52398
Merck$10,710,400,03189
Teva Pharmaceutical Industries$10,242,576,79696
GlaxoSmithKline$9,572,803,40650
Purdue Pharma$9,278,372,78711
AbbVie$7,560,456,40484
Takeda Pharmaceutical$3,987,516,44732
Endo International$3,311,990,66730
Eli Lilly$2,831,299,67626

Individual Penalty Records:

Click on the company or penalty amount for more information on each case. Click on the parent name to reach the summary page for that parent company.

Download results as CSV or XML or Save your search (Click here for information on download subscriptions)
CompanyCurrent Parent sort iconPrimary Offense TypeYearAgencyPenalty Amount
Wockhardt USAWockhardt LimitedMedicare Coverage Gap Discount Program violation2020CMS$111,824
Mylan Specialty, L.P.Viatrisoff-label or unapproved promotion of medical products2013MA-AG$250,000
UCB Inc.UCBoff-label or unapproved promotion of medical products2011FDA$34,000,000
UCB Inc.UCBoff-label or unapproved promotion of medical products2011MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $9,893,322
Cephalon IncTeva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2008FDA$425,000,000
AndaTeva Pharmaceutical IndustriesControlled Substances Act violation2016WV-AG$1,800,000
Cephalon Inc.Teva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2008MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $116,000,000
Cephalon, Inc.Teva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2008CT-AG$6,150,000
Teva PharmaceuticalsTeva Pharmaceutical IndustriesControlled Substances Act violation2019OK-AG$85,000,000
Teva Pharmaceutical Industries Ltd.Teva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2022TX-AG$225,000,000
Teva Pharmaceutical IndustriesTeva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2022FL-AG$278,826,499
Teva Pharmaceutical IndustriesTeva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2022RI-AG$21,000,000
Teva Pharmaceutical IndustriesTeva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2022WV-AG$83,000,000
Teva PharmaceuticalsTeva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2022MULTI-AG$4,250,000,000
Teva ParmaceuticalsTeva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2022CA-SFCA$27,000,000
Teva Pharmaceuticals, Ltd.Teva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2022NY-AG$313,343,793
Teva Pharmaceutical IndustriesTeva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2022MULTI-AG$8,200,000
Teva Pharmaceuticals, Inc.Teva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2023KY-AG$71,477,474
TevaTeva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2024MD-AG$70,281,867
Shire Pharmaceuticals LLCTakeda Pharmaceuticaloff-label or unapproved promotion of medical products2014FDA$56,500,000
Shire Pharmaceuticals LLCTakeda Pharmaceuticaloff-label or unapproved promotion of medical products2014MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $20,786,034
Sandoz, Inc.Sandoz GroupHHS civil monetary penalties2015HHSOIG$12,640,000
Sandoz, Inc.Sandoz GroupHHS civil monetary penalties2011HHSOIG$230,000
InterMune Inc.Rocheoff-label or unapproved promotion of medical products2006FDA$36,900,000
Intermune, Inc.RocheMedicare Coverage Gap Discount Program violation2013CMS$5,641
Intermune, Inc.RocheMedicare Coverage Gap Discount Program violation2013CMS$16,215
Genentech Inc.Rocheoff-label or unapproved promotion of medical products2000MULTI-AG$19,000,000
InterMune Inc.Rocheoff-label or unapproved promotion of medical products2006MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,700,000
Purdue Frederick Company, Inc. and Purdue Pharma, L.P.Purdue PharmaControlled Substances Act violation2007NV-AG$1,047,787
Purdue PharmaPurdue Pharmaoff-label or unapproved promotion of medical products2007MULTI-AG$19,500,000
Purdue PharmaPurdue PharmaControlled Substances Act violation2019OK-AG$270,000,000
Purdue Pharma, L.P.Purdue PharmaControlled Substances Act violation2015NY-AG$75,000
Wyeth Pharmaceuticals Inc.Pfizeroff-label or unapproved promotion of medical products2013FDA$490,900,000
Pfizer Inc.Pfizeroff-label or unapproved promotion of medical products2011FDA$14,500,000
Pfizer Inc.Pfizeroff-label or unapproved promotion of medical products2009FDA$2,300,000,000
Warner-LambertPfizeroff-label or unapproved promotion of medical products2004FDA$430,000,000
PfizerPfizeroff-label or unapproved promotion of medical products2014MULTI-AG$35,000,000
Pfizer Inc.Pfizeroff-label or unapproved promotion of medical products2008MULTI-AG$60,000,000
Pfizer Inc.Pfizeroff-label or unapproved promotion of medical products2013MA-AG$375,000
Pfizer Inc.Pfizeroff-label or unapproved promotion of medical products2012MULTI-AG$42,900,000
Warner-LambertPfizeroff-label or unapproved promotion of medical products2004MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $190,000,000
Wyeth Pharmaceuticals, Inc.Pfizeroff-label or unapproved promotion of medical products2013MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $257,400,000
Elan Corporation PLCPerrigooff-label or unapproved promotion of medical products2010FDA$203,000,000
Elan Corp.Perrigooff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $43,399,040
Otsuka American Pharmaceutical Inc.Otsuka Pharmaceuticaloff-label or unapproved promotion of medical products2008FDA$4,000,000
Otsuka American Pharmaceutical Inc.Otsuka Pharmaceuticaloff-label or unapproved promotion of medical products2008MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,700,000
OrganonOrganon & Co.off-label or unapproved promotion of medical products2014MULTI-AG$31,000,000
Novo Nordisk Inc.Novo Holdings A/Soff-label or unapproved promotion of medical products2011FDA$25,000,000
Novo Nordisk Inc.Novo Holdings A/Soff-label or unapproved promotion of medical products2011MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,574,209
Novo Nordisk Inc.Novo Holdings A/Soff-label or unapproved promotion of medical products2017CA-INS$1,100,000
Novartis Pharmaceuticals CorporationNovartisoff-label or unapproved promotion of medical products2010FDA$422,500,000
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals CorporationNovartisoff-label or unapproved promotion of medical products2010FDA$72,500,000
Novartis Pharmaceuticals CorporationNovartisoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $88,258,694
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals CorporationNovartisoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $29,000,000
Novartis PharmaceuticalsNovartisoff-label or unapproved promotion of medical products2012TX-AG$6,638,250
Serono, S.A.Merck KGaA (EMD)off-label or unapproved promotion of medical products2005FDA$704,000,000
Serono Inc.Merck KGaA (EMD)off-label or unapproved promotion of medical products2005MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $262,000,000
Merck, Sharp & DohmeMerckoff-label or unapproved promotion of medical products2011FDA$950,000,000
Inspire Pharmaceuticals Inc.Merckoff-label or unapproved promotion of medical products2015USAO$5,900,000
Schering-Plough CorporationMerckoff-label or unapproved promotion of medical products2006USAO$435,000,000
Inspire PharmaceuticalsMerckoff-label or unapproved promotion of medical products2015MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,000,000
Merck Sharp & Dohme Corp.Merckoff-label or unapproved promotion of medical products2012MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $201,975,000
Schering-Plough CorporationMerckoff-label or unapproved promotion of medical products2006MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $91,602,000
Mallinckrodt LLCMallinckrodtControlled Substances Act violation2017DEA$35,000,000
MallinckrodtMallinckrodtControlled Substances Act violation2020MULTI-AG$1,600,000,000
Johnson & JohnsonJohnson & Johnsonoff-label or unapproved promotion of medical products2013FDA$2,200,000,000
Scios Inc.Johnson & Johnsonoff-label or unapproved promotion of medical products2011FDA$85,000,000
Ortho-McNeil Pharmaceutical LLCJohnson & Johnsonoff-label or unapproved promotion of medical products2010FDA$81,000,000
Janssen Pharmaceuticals, Inc.Johnson & Johnsonoff-label or unapproved promotion of medical products2013USAO$410,000,000
Johnson & JohnsonJohnson & JohnsonControlled Substances Act violation2008USAO$511,000
Janssen Ortho LLC and Janssen Pharmaceuticals, Inc.Johnson & Johnsonoff-label or unapproved promotion of medical products2014MT-AG$5,900,000
Janssen Pharmaceuticals, Inc.Johnson & Johnsonoff-label or unapproved promotion of medical products2012MULTI-AG$181,000,000
Janssen Pharmaceuticals, Inc.Johnson & Johnsonoff-label or unapproved promotion of medical products2013MA-AG$15,100,000
Johnson & JohnsonJohnson & Johnsonoff-label or unapproved promotion of medical products2013MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $541,000,000
Johnson & JohnsonJohnson & Johnsonoff-label or unapproved promotion of medical products2012TX-AG$158,000,000
Ortho-McNeil Pharmaceutical LLCJohnson & Johnsonoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,681,516
Johnson & JohnsonJohnson & Johnsonoff-label or unapproved promotion of medical products2021MULTI-AG$5,000,000,000
Janssen PharmaceuticalsJohnson & Johnsonoff-label or unapproved promotion of medical products2022WV-AG$99,000,000
Janssen Pharmaceuticals/Johnson & JohnsonJohnson & Johnsonoff-label or unapproved promotion of medical products2022NH-AG$40,500,000
Johnson & JohnsonJohnson & Johnsonoff-label or unapproved promotion of medical products2022NH-AG$40,500,000
Johnson & JohnsonJohnson & Johnsonoff-label or unapproved promotion of medical products2024WA-AG$149,500,000
Jazz Pharmaceuticals Inc.Jazz Pharmaceuticalsoff-label or unapproved promotion of medical products2007USAO$20,000,000
Indivior plcIndivior PLCoff-label or unapproved promotion of medical products2021MULTI-AG$300,000,000
Hikma PharmaceuticalsHikma Pharmaceuticalsoff-label or unapproved promotion of medical products2024MULTI-AG$150,000,000
Glenmark Pharmaceuticals, Inc.Glenmark PharmaceuticalsHHS civil monetary penalties2015HHSOIG$2,887,300
GlaxoSmithKline LLCGlaxoSmithKlineoff-label or unapproved promotion of medical products2012FDA$3,000,000,000
GlaxoSmithKlineGlaxoSmithKlineoff-label or unapproved promotion of medical products2012MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $477,792,391
GlaxoSmithKlineGlaxoSmithKlineoff-label or unapproved promotion of medical products2010KY-AG$3,700,000
GlaxoSmithKlineGlaxoSmithKlineoff-label or unapproved promotion of medical products2009KY-AG$661,860
GlaxoSmithKline, LLCGlaxoSmithKlineoff-label or unapproved promotion of medical products2013MD-AG$15,000,000
Endo Health Solutions Inc.Endo Internationaloff-label or unapproved promotion of medical products2014FDA$192,700,000
Par Pharmaceutical Companies Inc.Endo Internationaloff-label or unapproved promotion of medical products2013FDA$45,000,000
Endo Health SolutionEndo Internationaloff-label or unapproved promotion of medical products2014MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $173,000,000
Par Pharmaceutical Companies Inc.Endo Internationaloff-label or unapproved promotion of medical products2013MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $22,500,000
Endo PharmaceuticalsEndo InternationalControlled Substances Act violation2020OK-AG$8,750,000
Endo Health SolutionsEndo Internationaloff-label or unapproved promotion of medical products2021NY-AG$50,000,000
Endo Health Solutions Inc. and Endo Pharmaceuticals Inc.Endo Internationaloff-label or unapproved promotion of medical products2022FL-AG$65,000,000
Endo Health Solutions and Endo PharmaceuticalsEndo Internationaloff-label or unapproved promotion of medical products2022FL-AG$65,000,000
Endo PharmaceuticalsEndo Internationaloff-label or unapproved promotion of medical products2022CA-SFCA$10,000,000
Endo International plcEndo Internationaloff-label or unapproved promotion of medical products2022MULTI-AG$450,000,000
Eli Lilly and CompanyEli Lillyoff-label or unapproved promotion of medical products2009FDA$1,415,000,000
(*): Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting.